University of Minnesota. Driven to Discover.
Immune response lasted 2.5 years for the vaccines, the longest yet in ongoing studies of Ebola immunization.
Also, phase 2 trials just launched for two prime-boost Ebola vaccine regimens.
Other Ebola developments include the departure of Cuba's team from Liberia, new information on evacuee contact monitoring, and outbreak case totals.
A clinical trial of 2 Ebola vaccine candidates was launched today near Liberia's capital, but falling case numbers may pose problems.
Ebola cases are increasing exponentially in Liberia, where taxis might transmit disease.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.